Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3 -ITD Allelic Ratio in FLT3 -ITD–Positive Acute Myelogenous Leukemia-Reference-Cited by-同舟云学术

Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3 -ITD Allelic Ratio in FLT3 -ITD–Positive Acute Myelogenous Leukemia

Published:2016-07 Issue:7 Volume:22 Page:1218-1226
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Oran Betül,Cortes Jorge,Beitinjaneh Amer,Chen Hsiang-Chun,de Lima Marcos,Patel Keyur,Ravandi Farhad,Wang Xuemei,Brandt Mark,Andersson Borje S.,Ciurea Stefan,Santos Fabio P.,de Padua Silva Leandro,Shpall Elizabeth J.,Champlin Richard E.,Kantarjian Hagop,Borthakur Gautam

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference41 articles.

1. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

2. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm;Fröhling;Blood,2002

3. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis;Thiede;Blood,2002

4. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia;Gale;Blood,2008

5. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study;Whitman;Blood,2010

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and Challenges in the Treatment of AML;American Society of Clinical Oncology Educational Book;2024-06

2. Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia;Scientific Reports;2024-04-12

3. Outcomes and prognosis of haploidentical haematopoietic stem cell transplantation in children with FLT3-ITD mutated acute myeloid leukaemia;Bone Marrow Transplantation;2024-03-05

4. Hematopoietic Cell Transplantation in Adult With Acute Myeloid Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus;Current Oncology;2023-12-12